Current and historical daily PE Ratio for Xlife Sciences AG (
XSWX:XLS
) from 2022 to May 27 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Xlife Sciences AG stock (XSWX:XLS) PE ratio as of May 27 2024 is 15.63.
More Details
Xlife Sciences AG (XSWX:XLS) PE Ratio (TTM) Chart
Xlife Sciences AG (XSWX:XLS) PE Ratio (TTM) Historical Data
View and export this data going back to 2022. Start your Free Trial
Total 590
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| Xlife Sciences AG PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-27 | 15.6 | 2024-03-18 | 24.2 |
| 2024-05-24 | 15.6 | 2024-03-15 | 22.7 |
| 2024-05-23 | 16.4 | 2024-03-14 | 23.3 |
| 2024-05-22 | 16.0 | 2024-03-13 | 23.8 |
| 2024-05-21 | 16.4 | 2024-03-12 | 23.1 |
| 2024-05-17 | 16.7 | 2024-03-11 | 22.7 |
| 2024-05-16 | 16.5 | 2024-03-08 | 21.5 |
| 2024-05-15 | 17.0 | 2024-03-07 | 21.6 |
| 2024-05-14 | 17.6 | 2024-03-06 | 19.2 |
| 2024-05-13 | 17.3 | 2024-03-05 | 19.2 |
| 2024-05-10 | 17.0 | 2024-03-04 | 19.3 |
| 2024-05-08 | 17.0 | 2024-03-01 | 19.2 |
| 2024-05-07 | 16.8 | 2024-02-29 | 19.8 |
| 2024-05-06 | 16.6 | 2024-02-28 | 20.1 |
| 2024-05-03 | 16.1 | 2024-02-27 | 20.7 |
| 2024-05-02 | 15.4 | 2024-02-26 | 20.7 |
| 2024-04-30 | 15.4 | 2024-02-23 | 21.2 |
| 2024-04-29 | 15.8 | 2024-02-22 | 22.3 |
| 2024-04-26 | 16.5 | 2024-02-21 | 22.5 |
| 2024-04-25 | 16.5 | 2024-02-20 | 23.2 |
| 2024-04-24 | 16.5 | 2024-02-19 | 23.6 |
| 2024-04-23 | 16.8 | 2024-02-16 | 24.1 |
| 2024-04-22 | 16.0 | 2024-02-15 | 23.2 |
| 2024-04-19 | 16.3 | 2024-02-14 | 23.3 |
| 2024-04-18 | 16.4 | 2024-02-13 | 22.9 |
| 2024-04-17 | 16.4 | 2024-02-12 | 22.1 |
| 2024-04-16 | 17.3 | 2024-02-09 | 22.3 |
| 2024-04-15 | 19.0 | 2024-02-08 | 22.3 |
| 2024-04-12 | 17.3 | 2024-02-07 | 23.0 |
| 2024-04-11 | 17.8 | 2024-02-06 | 22.4 |
| 2024-04-10 | 17.6 | 2024-02-05 | 22.8 |
| 2024-04-09 | 18.1 | 2024-02-02 | 22.9 |
| 2024-04-08 | 18.3 | 2024-02-01 | 24.0 |
| 2024-04-05 | 20.5 | 2024-01-31 | 23.5 |
| 2024-04-04 | 20.9 | 2024-01-30 | 23.5 |
| 2024-04-03 | 20.8 | 2024-01-29 | 23.3 |
| 2024-04-02 | 21.1 | 2024-01-26 | 23.6 |
| 2024-03-28 | 21.6 | 2024-01-25 | 23.1 |
| 2024-03-27 | 21.7 | 2024-01-24 | 22.9 |
| 2024-03-26 | 21.6 | 2024-01-23 | 21.6 |
| 2024-03-25 | 22.3 | 2024-01-22 | 22.3 |
| 2024-03-22 | 22.0 | 2024-01-19 | 21.6 |
| 2024-03-21 | 22.4 | 2024-01-18 | 22.3 |
| 2024-03-20 | 22.6 | 2024-01-17 | 21.8 |
| 2024-03-19 | 24.5 | 2024-01-16 | 22.6 |
Xlife Sciences AG (XSWX:XLS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Xlife Sciences AG
ISIN : CH0461929603
Share Class Description:
XSWX:XLS: Ordinary SharesDescription
Xlife Sciences AG is a Swiss incubator and accelerator company focused on the value development and commercialization of research projects from universities and other life science research institutions, to provide solutions for high unmet medical needs. It holds majority or minority interests in project companies that are engaged in areas of the company's reportable segments which include Technology platforms, Medical Technology, Biotechnology/Therapeutics, and Artificial intelligence/digital medicine.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers